Esoterix, Inc. Coagulation
Records under this name other than patents Esoterix, Inc. Coagulation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Esoterix, Inc. Coagulation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,994,983 | Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage Formerly held Term ended Term ended Feb 1, 2021 · USPTO record | Term ended | Term ended Feb 1, 2021 | USPTO record |
| US 6,967,083 | Thromboxane B2 metabolite methods for optimizing aspirin dosage Formerly held Lapsed on the fee record Ended Nov 22, 2017 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2017 | USPTO record |